Eudaimonia Partners’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-9,394
Closed -$509K 356
2022
Q2
$509K Buy
9,394
+3,923
+72% +$228K 0.09% 215
2022
Q1
$314K Buy
+5,471
New +$280K 0.05% 310
2021
Q3
$211K Buy
5,022
+121
+2% +$5.23K 0.04% 362
2021
Q2
$217K Buy
4,901
+289
+6% +$13.4K 0.04% 357
2021
Q1
$215K Sell
4,612
-304
-6% -$13.4K 0.04% 318
2020
Q4
$190K Buy
4,916
+1,063
+28% +$38K 0.04% 318
2020
Q3
$111K Buy
3,853
+20
+0.5% +$563 0.03% 389
2020
Q2
$103K Sell
3,833
-65
-2% -$1.69K 0.04% 353
2020
Q1
$92K Sell
3,898
-1,059
-21% -$29.1K 0.04% 347
2019
Q4
$147K Buy
+4,957
New +$131K 0.06% 284

Other funds holding CTVA

Eudaimonia Partners's CTVA Position: Q3 2022 in Review

Eudaimonia Partners sold out of Corteva (CTVA) in Q3 2022, closing a stake of 9,394 shares — an estimated $509K sold.

Eudaimonia Partners first reported a position in CTVA in Q4 2019 and held it in 10 quarters. The position peaked at $509K in Q2 2022. 1,225 funds tracked by Wall St. Rank hold CTVA as of Q3 2022.

  • Eudaimonia Partners reported no remaining Corteva position as of Q3 2022 after selling out during the quarter.
  • Eudaimonia Partners sold 9,394 Corteva shares in Q3 2022, an estimated $509K.
  • Eudaimonia Partners first reported a position in Corteva in Q4 2019 and held it in 10 quarters.
  • Eudaimonia Partners's Corteva position peaked at $509K in Q2 2022.
  • 1,225 funds tracked by Wall St. Rank held Corteva as of Q3 2022.

Based on Eudaimonia Partners's 13F filing for Q3 2022, filed 4 Nov 2022.